Here is my interpretation the COVID-19 trial announcement and comments from SI in the webcast, summarised in the form of a graph.
1 indicates the patient population when the trial was started
2 indicates the patient population when the trial was stopped
3 indicates the patient population Mesoblast and Novartis might seek to target after the trial data is unblinded
Keen to hear comments from others.
- Forums
- ASX - By Stock
- Ann: Mesoblast Update on COVID-19 ARDS Trial
Here is my interpretation the COVID-19 trial announcement and...
-
-
- There are more pages in this discussion • 332 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.17 |
Change
0.065(5.88%) |
Mkt cap ! $1.290B |
Open | High | Low | Value | Volume |
$1.10 | $1.19 | $1.09 | $6.854M | 6.009M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 10613 | $1.17 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.18 | 32236 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 552 | 1.180 |
22 | 243345 | 1.175 |
13 | 217405 | 1.170 |
13 | 116003 | 1.165 |
7 | 48857 | 1.160 |
Price($) | Vol. | No. |
---|---|---|
1.185 | 79179 | 10 |
1.190 | 191121 | 17 |
1.195 | 118466 | 11 |
1.200 | 347244 | 30 |
1.205 | 8000 | 2 |
Last trade - 12.24pm 12/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |